Supplemental material
Open access
1,942
Views
0
CrossRef citations to date
0
Altmetric
RSV
Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol
Narmeen Mallaha Genetics, Vaccines and Pediatric Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago prde Compostela (IDIS), Santiago de Compostela, Spain;b WHO Collaborating Centre for Vaccine Safety, Santiago de Compostela, Spain;c Department of Preventive Medicine, University of Santiago de Compostela (USC), Santiago de Compostela, Spain;d Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBER-ESP), Instituto de Salud Carlos III, Madrid, SpainView further author information
, Sonia Ares-Gómeza Genetics, Vaccines and Pediatric Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago prde Compostela (IDIS), Santiago de Compostela, Spain;b WHO Collaborating Centre for Vaccine Safety, Santiago de Compostela, Spain;e Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, SpainView further author information
, Jacobo Pardo-Secoa Genetics, Vaccines and Pediatric Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago prde Compostela (IDIS), Santiago de Compostela, Spain;b WHO Collaborating Centre for Vaccine Safety, Santiago de Compostela, Spain;e Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain;f Genética de Poblaciones en Biomedicina (GenPoB) Research Group, Instituto de Investigación Sanitaria (IDIS), Hospital Clínico Universitario de Santiago (SERGAS), Santiago de Compostela, SpainView further author information
, Alberto Malvar-Pintosg Department of Epidemiology, Dirección Xeral de Saúde Pública, Consellería de Sanidade, Xunta de Galicia, Galicia, SpainView further author information
, María-Isolina Santiago-Pérezg Department of Epidemiology, Dirección Xeral de Saúde Pública, Consellería de Sanidade, Xunta de Galicia, Galicia, SpainView further author information
, Olaia Pérez-Martínezg Department of Epidemiology, Dirección Xeral de Saúde Pública, Consellería de Sanidade, Xunta de Galicia, Galicia, SpainView further author information
, María-Teresa Otero-Barrósg Department of Epidemiology, Dirección Xeral de Saúde Pública, Consellería de Sanidade, Xunta de Galicia, Galicia, SpainView further author information
, Nuria Suárez-Gaicheg Department of Epidemiology, Dirección Xeral de Saúde Pública, Consellería de Sanidade, Xunta de Galicia, Galicia, SpainView further author information
, Rolf Kramerh Sanofi Vaccines, Lyon, FranceView further author information
, Jing Jinh Sanofi Vaccines, Lyon, FranceView further author information
, Leticia Platero-Alonsoh Sanofi Vaccines, Lyon, FranceView further author information
, Rosa-María Alvárez-Gili Department of Communicable Diseases, Dirección Xeral de Saúde Pública, Consellería de Sanidade, Xunta de Galicia, Galicia, SpainView further author information
, Olga-María Ces-Ozoresi Department of Communicable Diseases, Dirección Xeral de Saúde Pública, Consellería de Sanidade, Xunta de Galicia, Galicia, SpainView further author information
, Victoria Nartallo-Penasi Department of Communicable Diseases, Dirección Xeral de Saúde Pública, Consellería de Sanidade, Xunta de Galicia, Galicia, SpainView further author information
, Susana Mirás-Carballali Department of Communicable Diseases, Dirección Xeral de Saúde Pública, Consellería de Sanidade, Xunta de Galicia, Galicia, SpainView further author information
, Marta Piñeiro-Sotelog Department of Epidemiology, Dirección Xeral de Saúde Pública, Consellería de Sanidade, Xunta de Galicia, Galicia, SpainView further author information
, Juan-Manuel González-Pérezj Subdirección de Sistemas y Tecnologías de la Información, Consellería de Sanidade, Xunta de Galicia, Galicia, SpainView further author information
, Carmen Rodríguez-Tenreiroa Genetics, Vaccines and Pediatric Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago prde Compostela (IDIS), Santiago de Compostela, Spain;b WHO Collaborating Centre for Vaccine Safety, Santiago de Compostela, Spain;e Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, SpainView further author information
, Irene Rivero-Callea Genetics, Vaccines and Pediatric Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago prde Compostela (IDIS), Santiago de Compostela, Spain;b WHO Collaborating Centre for Vaccine Safety, Santiago de Compostela, Spain;e Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain;k Translational Pediatrics and Infectious Diseases, Hospital Clínico Universitario de Santiago (SERGAS) and University of Santiago de Compostela (USC), Santiago de Compostela, SpainView further author information
, Antonio Salasa Genetics, Vaccines and Pediatric Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago prde Compostela (IDIS), Santiago de Compostela, Spain;e Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain;f Genética de Poblaciones en Biomedicina (GenPoB) Research Group, Instituto de Investigación Sanitaria (IDIS), Hospital Clínico Universitario de Santiago (SERGAS), Santiago de Compostela, Spain;l Unidade de Xenética, Instituto de Ciencias Forenses, Facultade de Medicina, Universidade de Santiago de Compostela (USC), SpainView further author information
, Carmen Durán-Parrondom Dirección Xeral de Saúde Pública, Consellería de Sanidade, Xunta de Galicia, Galicia, SpainView further author information
& Federico Martinón-Torresa Genetics, Vaccines and Pediatric Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago prde Compostela (IDIS), Santiago de Compostela, Spain;b WHO Collaborating Centre for Vaccine Safety, Santiago de Compostela, Spain;e Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain;k Translational Pediatrics and Infectious Diseases, Hospital Clínico Universitario de Santiago (SERGAS) and University of Santiago de Compostela (USC), Santiago de Compostela, SpainCorrespondence[email protected]
https://orcid.org/0000-0002-9023-581XView further author information
Article: 2348135
|
Received 28 Feb 2024, Accepted 23 Apr 2024, Published online: 13 May 2024
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.